Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Schizophrenia Bulletin|February 21, 2018
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early PsychosisPhilippe Conus, Larry J Seidman, Margot Fournier, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 14, 2019
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)Paolo Fusar-Poli, Michael Bauer, Stefan Borgwardt, et al.
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Molecular Psychiatry|August 14, 2023
Towards a youth mental health paradigm: a perspective and roadmapPeter J Uhlhaas, Christopher G Davey, Urvakhsh Meherwan Mehta, et al.
JAMA Psychiatry|January 12, 2022
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in SchizophreniaAntonio F Pardiñas, Sophie E Smart, Isabella R Willcocks, et al.
Molecular Psychiatry|February 22, 2023
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysisKate Merritt, Robert A McCutcheon, André Aleman, et al.
Journal of Affective Disorders|December 31, 2022
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adultsMarco Solmi, Trevor Thompson, Andrés Estradé, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 24, 2024
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in AdolescentsMarco Solmi, Trevor Thompson, Samuele Cortese, et al.
Pageof 11